Prosecution Insights
Last updated: April 19, 2026

Quell Therapeutics Limited

3 pending office actions

Portfolio Summary

3
Total Pending OAs
1
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18042927 NUCLEIC ACID CONSTRUCTS FOR EXPRESSING POLYPEPTIDES IN CELLS LEE, YIE CHIA 1642 Non-Final OA Feb 24, 2023
17926374 POLYPEPTIDE USEFUL IN ADOPTIVE CELL THERAPY ROGERS, ERIC JASON 1638 Non-Final OA Nov 18, 2022
17771191 CHIMERIC ANTIGEN RECEPTOR SPECIFIC FOR HLA ZHU, JIANJIAN 1631 Final Rejection Apr 22, 2022

Managing Quell Therapeutics Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month